Every organisation that conducts drug and alcohol testing knows its own positive rate. Far fewer know how that rate compares to their peers. Is a 2.5% positive rate good or bad? Without context, it is impossible to say.
Benchmarking — comparing your testing results against industry averages and peer organisations — provides that context. It helps you calibrate your program, set realistic targets, and identify whether your results reflect effective management or a gap in your approach.
Australian Industry Positive Rate Data
Comprehensive, publicly available benchmarking data for Australian workplace drug and alcohol testing is limited compared to the United States, where organisations like Quest Diagnostics and the Substance Abuse and Mental Health Services Administration (SAMHSA) publish detailed annual reports. However, Australian data is available from several sources.
What the Data Shows
- Overall positive rates — Australian workplace testing laboratories have historically reported overall oral fluid positive rates in the range of 5% to 10%, though this varies significantly by industry, region, and testing type. Urine testing positive rates tend to be somewhat higher due to longer detection windows.
- Methamphetamine — Methamphetamine (including “ice”) has been the most commonly detected illicit substance in Australian workplace testing for several years, particularly in mining, construction, and transport sectors.
- Cannabis — Cannabis remains the second most commonly detected substance. With the expansion of medicinal cannabis prescriptions, organisations are increasingly needing to distinguish between recreational and prescribed use.
- Alcohol — Alcohol positive rates are generally lower in random testing, but alcohol is frequently detected in for-cause and post-incident testing.
Industry Variation
Positive rates vary significantly by industry. Sectors with established, mature testing programs — such as mining and rail — tend to report lower positive rates than sectors where testing is newer or less frequent. This does not necessarily mean that substance use is lower — it may reflect the deterrent effect of a well-known, consistently enforced program.
- Mining and resources — Typically lower positive rates due to rigorous, frequent testing and strong deterrent effect. However, methamphetamine detection remains a concern.
- Construction — Moderate to higher positive rates, reflecting a younger workforce demographic and less consistent testing across the sector.
- Transport and logistics — Variable, with operators subject to Chain of Responsibility legislation generally maintaining more robust programs.
- Manufacturing — Moderate positive rates, with variation depending on whether the site is safety-critical (e.g., heavy machinery) or lower-risk.
- Office-based and professional services — Lower positive rates where testing is conducted, though testing is less common in these sectors.
Factors That Affect Your Positive Rate
Before comparing your positive rate to any benchmark, it is essential to understand the factors that influence the number. Two organisations in the same industry can have very different positive rates for reasons that have nothing to do with actual substance use prevalence.
Testing Type Mix
Pre-employment testing typically has a higher positive rate than random testing, because candidates have not yet been subject to the deterrent effect of an ongoing program. For-cause testing has a much higher positive rate because the test was triggered by observed indicators of impairment. An organisation that conducts mostly random testing will have a different overall positive rate than one that conducts mostly for-cause testing.
Specimen Type
Oral fluid testing has a shorter detection window than urine testing. This means oral fluid testing is more likely to detect recent use (relevant to impairment) but will miss use that occurred several days prior. The choice of specimen type directly affects the positive rate and must be controlled for when comparing across organisations.
Testing Frequency
Organisations that test more frequently tend to have lower positive rates over time, because the deterrent effect is stronger. A program that tests 100% of the workforce annually will likely report a lower positive rate than one that tests 25%, because the perceived probability of detection is higher.
Substance Panel
The number and type of substances tested for affects the positive rate. An organisation testing for a broad panel (including synthetic cannabinoids, prescription medications, and novel psychoactive substances) will detect more positives than one testing only for the standard five-substance panel.
Workforce Demographics
Age, gender, geographic location, and employment type all influence substance use patterns. A workforce that skews younger and male in a regional area will likely have a different positive rate than an older, metropolitan, professional workforce.
Why Comparison Matters
Despite the caveats, benchmarking serves several valuable purposes.
Calibrating Your Program
If your positive rate is significantly above your industry average, it may indicate that your program is detecting more — which could be a positive sign — or that your workforce has a more significant substance use issue than your peers. Either way, it warrants investigation.
Conversely, a very low positive rate compared to your peers may indicate an effective program with strong deterrent value. Or it may indicate under-testing, an inadequate substance panel, or a selection methodology that is not truly random.
Setting Targets
Benchmarks help you set realistic targets for program improvement. A target of zero positive results may be admirable in theory, but it is unrealistic in practice. A target of reducing your positive rate to below the industry average, or achieving a year-on-year reduction of a defined percentage, is both realistic and measurable.
Communicating with Stakeholders
Boards, clients, and regulators all understand benchmarks. “Our positive rate is 1.8% against an industry average of 4.5%” is a more powerful statement than “Our positive rate is 1.8%” in isolation. It demonstrates that your program is performing well relative to the sector.
Using Benchmarks to Calibrate Your Program
- Above industry average — Investigate whether the elevated rate reflects genuine higher risk, a change in substance availability, or a gap in your program (e.g., inadequate education, insufficient EAP access, or weak leadership commitment).
- At industry average — Your program is performing consistently with your peers. Look for opportunities for incremental improvement — increased testing frequency, expanded substance panel, or enhanced supervisor training.
- Below industry average — Your program appears to be outperforming your peers. Validate this by checking for potential under-reporting, testing methodology differences, or sample size issues. If the low rate is genuine, document what you are doing well — it may be a model for other parts of the organisation or industry.
Limitations of Benchmarking
Benchmarking is a useful tool, not a definitive answer. Be aware of its limitations:
- Data quality varies. Benchmark data is only as reliable as the organisations contributing to it. Self-reported data may be subject to reporting bias.
- Definitions differ. “Positive rate” may be calculated differently across organisations and laboratories. Some include non-negative presumptive results; others count only confirmed positives.
- Context is everything. An organisation that tests 100% of its workforce and achieves a 3% positive rate is in a very different position to one that tests 10% and achieves the same rate.
- Benchmarks are backward-looking. Published industry data is typically 12 to 24 months old. The substance landscape can change rapidly.
Use benchmarks as one input into your program evaluation — not the sole determinant of whether your program is effective.
Want to see how your testing program stacks up? Start a free trial of FairTest and access trend reports, positive rate tracking, and the data you need to benchmark your program with confidence.